Point72 Hong Kong’s AMAG Pharmaceuticals AMAG Stock Holding History

Point72 Hong Kong’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,902	Closed	-$99K	–	1503
2019 Q2	$99K	Buy	+9,902	New	+$107K	0.03%	502
2018 Q4	–	Sell	-479	Closed	-$10K	–	1335
2018 Q3	$10K	Buy	+479	New	+$10.9K	﹤0.01%	666
2017 Q4	–	Sell	-758	Closed	-$14K	–	1193
2017 Q3	$14K	Buy	+758	New	+$14.1K	0.01%	452
2017 Q1	–	Sell	-125	Closed	-$4K	–	1107
2016 Q4	$4K	Buy	+125	New	+$3.73K	﹤0.01%	741

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Hong Kong's AMAG Position: Q3 2019 in Review

Point72 Hong Kong sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 9,902 shares — an estimated $99K sold.

Point72 Hong Kong first reported a position in AMAG in Q4 2016 and held it in 4 quarters. The position peaked at $99K in Q2 2019. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

Point72 Hong Kong reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Point72 Hong Kong sold 9,902 AMAG Pharmaceuticals shares in Q3 2019, an estimated $99K.
Point72 Hong Kong first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 4 quarters.
Point72 Hong Kong's AMAG Pharmaceuticals position peaked at $99K in Q2 2019.
156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Point72 Hong Kong's 13F filing for Q3 2019, filed 14 Nov 2019.